We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

75 hedge funds and large institutions have $16.3M invested in Cognition Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.38% less ownership

Funds ownership: 24.35% → 23.97% (-0.38%)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 78 → 75 (-3)

44% less capital invested

Capital invested by funds: $29M → $16.3M (-$12.8M)

Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
18
Reduced
14
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$233K
2
XT
XTX Topco
Cayman Islands
+$185K
3
HF
HRT Financial
New York
+$178K
4
Renaissance Technologies
Renaissance Technologies
New York
+$172K
5
SPC
Sigma Planning Corp
Michigan
+$142K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$284K
2
OAC
OMERS Administration Corp
Ontario, Canada
-$215K
3
GCM
Graham Capital Management
Connecticut
-$205K
4
Citadel Advisors
Citadel Advisors
Florida
-$157K
5
VC
Voss Capital
Texas
-$92.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPIG
51
Chicago Partners Investment Group
Illinois
$14.1K -$13 -11 -0.1%
Northwestern Mutual Wealth Management
52
Northwestern Mutual Wealth Management
Wisconsin
$13.3K – – –
Mercer Global Advisors
53
Mercer Global Advisors
Colorado
$12.1K – – –
Focus Partners Wealth
54
Focus Partners Wealth
Massachusetts
$11.4K – – –
CFG
55
Citizens Financial Group
Rhode Island
$10.4K – – –
Bank of New York Mellon
56
Bank of New York Mellon
New York
$10.2K +$15.7K +13,462 New
BFS
57
Bradley Foster & Sargent
Connecticut
$8.9K – – –
VPIM
58
Vanguard Personalized Indexing Management
California
$8.38K +$12.8K +11,034 New
MYIA
59
Mount Yale Investment Advisors
Colorado
$7.63K +$11.7K +10,040 New
VAS
60
Vestmark Advisory Solutions
Massachusetts
$7.63K +$11.7K +10,040 New
BIA
61
Barry Investment Advisors
Massachusetts
$7.59K – – –
MML Investors Services
62
MML Investors Services
Massachusetts
$7.59K – – –
RPGK
63
Retirement Planning Group (Kansas)
Kansas
$7.59K – – –
RSWM
64
Robertson Stephens Wealth Management
California
$7.59K – – –
SSA
65
Schonfeld Strategic Advisors
New York
$7.59K +$11.6K +10,000 New
TRCT
66
Tower Research Capital (TRC)
New York
$4.05K +$6.21K +5,339 New
Fifth Third Bancorp
67
Fifth Third Bancorp
Ohio
$3.8K – – –
Osaic Holdings
68
Osaic Holdings
Arizona
$2.43K -$1.63K -1,400 -30%
VCM
69
Versant Capital Management
Arizona
$2.33K +$1.22K +1,050 +52%
Wells Fargo
70
Wells Fargo
California
$2.32K +$58 +50 +2%
ASN
71
Advisory Services Network
Georgia
$1.9K +$2.91K +2,500 New
MCM
72
MAI Capital Management
Ohio
$190 – – –
SS
73
SBI Securities
Japan
$12 +$13 +11 +220%
CIAM
74
Caitong International Asset Management
Hong Kong
$1 -$114 -98 -99%
Fidelity Investments
75
Fidelity Investments
Massachusetts
$1 – – –
1 2
3
4

CGTX Hedge Fund Activity: Q1 2026 in Review

75 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q1 2026, worth a combined $16.3M — down 44% from $29M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CGTX and 13 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 18 added.

The largest buyer was CM Management, adding an estimated $233K. The largest seller was Jane Street, cutting an estimated $284K.

  • 75 institutional investors held Cognition Therapeutics (CGTX) as of Q1 2026, down from 78 in Q4 2025.
  • Funds reported $16.3M of Cognition Therapeutics stock for Q1 2026, down 44% quarter-over-quarter.
  • 13 funds opened new Cognition Therapeutics positions in Q1 2026 and 14 closed out, a net change of -1 holder.
  • The largest Cognition Therapeutics buyer in Q1 2026 was CM Management, an estimated $233K added.
  • The largest Cognition Therapeutics seller in Q1 2026 was Jane Street, an estimated $284K sold.

Based on aggregated 13F filings for Q1 2026.